BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
13 results:

  • 1. Forty Years of Helicobacter pylori: The African Perspective.
    Jaka H; Smith SI
    Dig Dis; 2024; 42(2):161-165. PubMed ID: 38128488
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
    Trottmann M; Blozik E; Hilbig M; LoVerdi D; Pedruzzi M; Scherer T; Weiss M; Pletscher M; Meier N
    Swiss Med Wkly; 2023 Sep; 153():3441. PubMed ID: 37774383
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
    Mauz-Körholz C; Landman-Parker J; Fernández-Teijeiro A; Attarbaschi A; Balwierz W; Bartelt JM; Beishuizen A; Boudjemaa S; Cepelova M; Ceppi F; Claviez A; Daw S; Dieckmann K; Fosså A; Gattenlöhner S; Georgi T; Hjalgrim LL; Hraskova A; Karlén J; Kurch L; Leblanc T; Mann G; Montravers F; Pears J; Pelz T; Rajić V; Ramsay AD; Stoevesandt D; Uyttebroeck A; Vordermark D; Körholz D; Hasenclever D; Wallace WH; Kluge R
    Lancet Oncol; 2023 Mar; 24(3):252-261. PubMed ID: 36858722
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
    Yang W; Cai J; Shen S; Gao J; Yu J; Hu S; Jiang H; Fang Y; Liang C; Ju X; Wu X; Zhai X; Tian X; Wang N; Liu A; Jiang H; Jin R; Sun L; Yang M; Leung AWK; Pan K; Zhang Y; Chen J; Zhu Y; Zhang H; Li C; Yang JJ; Cheng C; Li CK; Tang J; Zhu X; Pui CH
    Lancet Oncol; 2021 Sep; 22(9):1322-1332. PubMed ID: 34329606
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary Central Nervous System lymphoma: Clinical Evaluation of Automated Segmentation on Multiparametric MRI Using Deep Learning.
    Pennig L; Hoyer UCI; Goertz L; Shahzad R; Persigehl T; Thiele F; Perkuhn M; Ruge MI; Kabbasch C; Borggrefe J; Caldeira L; Laukamp KR
    J Magn Reson Imaging; 2021 Jan; 53(1):259-268. PubMed ID: 32662130
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytomegalovirus viremia and resistance patterns in immunocompromised children: An 11-year experience.
    Kim E; Asmar BI; Thomas R; Abdel-Haq N
    Pediatr Hematol Oncol; 2020 Mar; 37(2):119-128. PubMed ID: 31826701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins.
    Ren Z; van Andel H; de Lau W; Hartholt RB; Maurice MM; Clevers H; Kersten MJ; Spaargaren M; Pals ST
    Blood; 2018 Mar; 131(9):982-994. PubMed ID: 29212806
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
    Weycker D; Barron R; Kartashov A; Legg J; Lyman GH
    J Oncol Pharm Pract; 2014 Jun; 20(3):190-8. PubMed ID: 23824496
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma.
    Schaefer NG; Geschwind JF; Engles J; Buchanan JW; Wahl RL
    Transl Res; 2012 Jan; 159(1):51-7. PubMed ID: 22153810
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Central nervous system lymphoma and its significance].
    Zheng W; Lin NJ; Xie Y; Wang XP; Tu MF; Liu WP; Song YQ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1550-4. PubMed ID: 21914369
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathologic features and treatment outcomes in malignant lymphoma of pediatric and young adult patients in Korea: comparison of korean all-ages group and Western younger age group.
    Hwang IG; Yoo KH; Lee SH; Park YH; Lim TK; Lee SC; Park S; Park BB; Ko YH; Kim K; Koo HH; Kim WS
    Clin Lymphoma Myeloma; 2007 Nov; 7(9):580-6. PubMed ID: 18186966
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Radiotherapy of Hodgkin's disease in clinical stages I and II A: relapse of the disease and salvage therapy].
    Zanini M; Zucali R; Melegari M; Banfi A
    Radiol Med; 1983 Mar; 69(3):139-44. PubMed ID: 6403973
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Karyotype of peripheral blood lymphocytes in patients treated for Hodgkin disease].
    Cappelaere P; Lai JL; Caty A; Deminatti M; Demaille MC
    Bull Cancer; 1983; 70(1):31-9. PubMed ID: 6839032
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.